Merck & Co., Inc. (6MK.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 264.66B |
| Enterprise Value | 301.41B |
| P/E Ratio | 150.19 |
| PEG Ratio | -1.73 |
| Price/Sales Ratio | 5.39 |
| Price/Book Ratio | 8.12 |
| Enterprise/Revenue | 6.05 |
| Enterprise/EBITDA | 31.23 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.04 |
| Operating Margin | 0.16 |
AD
Management Effectiveness
| Return On Assets | 0.02 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 65.02B |
| Revenue/Share | 27.16 |
| Gross Profit | 52.99B |
| EBITDA | 28.26B |
| Net Income | 18.26B |
| Diluted EPS | 7.28 |
Balance Sheet
| Total Cash | 9.65B |
| Total Cash/Share | 3.89 |
| Total Debt | 53.78B |
| Total Debt/Equity | 1.2 |
| Current Ratio | 1.35 |
| Book Value Per Share | 18.14 |
Price History
| 52-Week Change | 69.57 |
| 52-Week High | 136.44 |
| 52-Week Low | 78.4 |
| Moving Average 50 Days | 129.33 |
| Moving Average 200 Days | 111.58 |
Statistics
| Average Volume | 1,521 |
| Shares Outstanding | 2.47B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 3.4 |
| Trailing Annual Dividend Yield | 2.31 |
| Payout Ratio | 3.41 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
